OVEREXPRESSION OF HUMAN LECITHIN CHOLESTERYL ACYLTRANSFERASE IN TRANSGENIC MICE
转基因小鼠中人卵磷脂胆固醇酰基转移酶的过度表达
基本信息
- 批准号:2576779
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Despite increased plasma concentrations of HDL, as well as apoA-I, LCAT
transgenic (L-tg) mice have enhanced (up to 5-fold) diet induced
atherosclerosis compared to age and sex matched controls. To investigate
potential mechanisms that may explain this paradoxical dissociation
between plasma concentrations of HDL and atherosclerosis we have used
recombinant adenovirus vectors to express, in vivo, two other proteins
that play a major role in HDL metabolism. Adenovirus-mediated expression
of HL and CETP in both control and L-tg mice demonstrated that compared
to the HDL in control animals, the apoA-I/A-II HDL in L-tg mice were
poorly hydrolyzed by HL and would not support the transport of
cholesteryl esters to apoB containing lipoproteins by CETP. Additionally,
baseline plasma concentrations of nascent, pre-B1-HDL, the most effector
particles for the efflux of cellular cholesterol, were significantly
reduced in L-tg mice. The decay plasma curve of L-tg mouse HDL after
injection of radiolabelled HDL-cholesterol ether isolated from control
and L-tg mice was significantly delayed from that of control mouse HDL.
In addition, the % of total cholesterol ether delivered to the liver, two
hours after injection of radiolabelled HDL, was significantly reduced
(P<0.001) for L-tg mice compared to controls (18% versus 33% of total
cholesterol ether).
These combined studies indicate that in the absence of CETP, LCAT
overexpression in mice leads to the formation of HDL particles with
abnormal composition and function, establishing one potential mechanism
that may account for the enhanced atherosclerosis observed in this animal
model. Thus, the process of reverse cholesterol transport, an important
mechanism by which HDL may modulate the development of atherosclerosis
is interrupted in L-tg mice. These studies demonstrate that HDL and
apoA-I plasma concentrations, alone, are not predictive of the
anti-atherogenic potential of HDL and functional studies are required to
determine whether increasing plasma HDL by different therapeutic
modalities will if fact, protect against the development of premature
cardiovascular disease.
尽管血浆HDL浓度增加,以及apoA-I,LCAT
转基因(L-tg)小鼠具有增强的(高达5倍)饮食诱导的
与年龄和性别匹配的对照组相比,动脉粥样硬化。 探讨
可能解释这种矛盾分离的潜在机制
血浆高密度脂蛋白浓度和动脉粥样硬化之间的关系
重组腺病毒载体以在体内表达两种其它蛋白质
在高密度脂蛋白代谢中起主要作用。腺病毒介导表达
HL和CETP在对照组和L-tg小鼠中的表达表明,
与对照动物的HDL相比,L-tg小鼠的apoA-I/A-II HDL
HL水解不良,不支持转运
胆固醇酯与含载脂蛋白B的脂蛋白。此外,本发明还
基线血浆浓度的新生,前B1-HDL,最效应
细胞胆固醇流出的颗粒,显着
在L-tg小鼠中降低。L-tg小鼠HDL的血浆衰减曲线
注射从对照品中分离的放射性标记HDL-胆固醇醚
而L-tg小鼠的HDL表达明显延迟于对照小鼠。
此外,传递到肝脏的总胆固醇醚的%,
在注射放射性标记的HDL后24小时,
L-tg小鼠与对照组相比(18%对33%)(P<0.001)
胆固醇醚)。
这些综合研究表明,在没有CETP,LCAT
在小鼠中的过度表达导致HDL颗粒的形成,
异常的组成和功能,建立一个潜在的机制,
这可以解释在这只动物中观察到的动脉粥样硬化增强
模型 因此,胆固醇的逆向转运过程,
HDL调节动脉粥样硬化发展的机制
在L-tg小鼠中被中断。这些研究表明,HDL和
apoA-I血浆浓度本身并不能预测
需要HDL的抗动脉粥样硬化潜力和功能研究,
确定不同治疗方法是否会增加血浆HDL
如果事实上,模式将防止不成熟的发展,
心血管疾病
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
S SANTAMARINA-FOJO其他文献
S SANTAMARINA-FOJO的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('S SANTAMARINA-FOJO', 18)}}的其他基金
MOLECULAR DEFECTS IN GENETIC DISORDERS OF LIPOPROTEIN METABOLISM
脂蛋白代谢遗传疾病中的分子缺陷
- 批准号:
3757646 - 财政年份:
- 资助金额:
-- - 项目类别:
LCAT-KNOCKOUT MICE--NEW ANIMAL MODEL FOR HUMAN LCAT DEFICIENCY
LCAT基因敲除小鼠——治疗人类LCAT缺陷的新动物模型
- 批准号:
2441406 - 财政年份:
- 资助金额:
-- - 项目类别:
ADENOVIRAL GENE REPLACEMENT OF HEPATIC LIPASE IN HL-DEFICIENT MICE
HL 缺陷小鼠肝脂肪酶的腺病毒基因替换
- 批准号:
3757647 - 财政年份:
- 资助金额:
-- - 项目类别:
OVEREXPRESSION OF HUMAN LECITHIN CHOLESTERYL ACYLTRANSFERASE IN TRANSGENIC MICE
转基因小鼠中人卵磷脂胆固醇酰基转移酶的过度表达
- 批准号:
3757645 - 财政年份:
- 资助金额:
-- - 项目类别:
OVEREXPRESSION OF HUMAN LECITHIN CHOLESTERYL ACYLTRANSFERASE IN TRANSGENIC MICE
转基因小鼠中人卵磷脂胆固醇酰基转移酶的过度表达
- 批准号:
6162693 - 财政年份:
- 资助金额:
-- - 项目类别:
ADENOVIRAL GENE TRANSFER OF APOE IN APOE DEFICIENT MICE
APOE 缺陷小鼠中 APOE 的腺病毒基因转移
- 批准号:
3757644 - 财政年份:
- 资助金额:
-- - 项目类别:
IN VITRO AND IN VIVO STRUCTURE/FUNCTION ANALYSIS OF LPL AND HL
LPL和HL的体外和体内结构/功能分析
- 批准号:
2576774 - 财政年份:
- 资助金额:
-- - 项目类别:
IN VITRO AND IN VIVO STRUCTURE/FUNCTION ANALYSIS OF LPL AND HL
LPL和HL的体外和体内结构/功能分析
- 批准号:
5203517 - 财政年份:
- 资助金额:
-- - 项目类别:
OVEREXPRESSION OF HUMAN LECITHIN CHOLESTERYL ACYLTRANSFERASE IN TRANSGENIC MICE
转基因小鼠中人卵磷脂胆固醇酰基转移酶的过度表达
- 批准号:
5203524 - 财政年份:
- 资助金额:
-- - 项目类别:
REDUCTION OF ATHEROSCLEROSIS IN APOE DEFICIENT MICE BY GENE THERAPY
通过基因治疗减少 APOE 缺陷小鼠的动脉粥样硬化
- 批准号:
5203523 - 财政年份:
- 资助金额:
-- - 项目类别:
相似海外基金
Targeted ablation of cerebral atherosclerosis using supramolecular self-assembly
利用超分子自组装靶向消融脑动脉粥样硬化
- 批准号:
24K21101 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Early-Career Scientists
Body composition and atherosclerosis-related biomarkers in women with endometriosis
子宫内膜异位症女性的身体成分和动脉粥样硬化相关生物标志物
- 批准号:
23K15842 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Early-Career Scientists
Targeted multimodal stimuli-responsive nanogels for atherosclerosis imaging and therapy
用于动脉粥样硬化成像和治疗的靶向多模式刺激响应纳米凝胶
- 批准号:
2880683 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Studentship
The Epigenetic Regulator Prdm16 Controls Smooth Muscle Phenotypic Modulation and Atherosclerosis Risk
表观遗传调节因子 Prdm16 控制平滑肌表型调节和动脉粥样硬化风险
- 批准号:
10537602 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Role of IL-6 trans signaling in atherosclerosis development and late-stage pathogenesis
IL-6反式信号传导在动脉粥样硬化发展和晚期发病机制中的作用
- 批准号:
10652788 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Novel Mechanisms Underlying the Development of Atherosclerosis
动脉粥样硬化发展的新机制
- 批准号:
10589484 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Alcohol Regulation of Endothelial Plasticity in Atherosclerosis
酒精对动脉粥样硬化内皮可塑性的调节
- 批准号:
10585070 - 财政年份:2023
- 资助金额:
-- - 项目类别:
From genotype to phenotype in a GWAS locus: the role of REST in atherosclerosis
GWAS 位点从基因型到表型:REST 在动脉粥样硬化中的作用
- 批准号:
10570469 - 财政年份:2023
- 资助金额:
-- - 项目类别:
The role of extracellular vesicle-associated MicroRNAs in HIV-associated atherosclerosis
细胞外囊泡相关 MicroRNA 在 HIV 相关动脉粥样硬化中的作用
- 批准号:
10619831 - 财政年份:2023
- 资助金额:
-- - 项目类别: